Targeted disruption of RAR and RXR, mainly RARα and RXRα in the embryonic stage, resulted in early postnatal or embryonic lethality and heart failure [183,184], suggesting that RARα and RXRα are the two main receptor subtypes that are involved in the regulation of cardiomyocyte differentiation and function. Here, RARA is linked to heart failure.